IONAMIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ionamin, and what generic alternatives are available?
Ionamin is a drug marketed by Ucb Inc and is included in one NDA.
The generic ingredient in IONAMIN is phentermine resin complex. There are seventeen drug master file entries for this compound. Additional details are available on the phentermine resin complex profile page.
Summary for IONAMIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 31 |
| Clinical Trials: | 2 |
| Patent Applications: | 3,771 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | IONAMIN at DailyMed |
Recent Clinical Trials for IONAMIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| New York State Psychiatric Institute | Phase 4 |
| AstraZeneca | Phase 4 |
| State University of New York - Upstate Medical University | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for IONAMIN
US Patents and Regulatory Information for IONAMIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ucb Inc | IONAMIN | phentermine resin complex | CAPSULE, EXTENDED RELEASE;ORAL | 011613-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Ucb Inc | IONAMIN | phentermine resin complex | CAPSULE, EXTENDED RELEASE;ORAL | 011613-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
